New Treatment Regimen for Latent Tuberculosis Infection - once a week, for 12 weeks (CDC video)

Dr. Kenneth Castro discusses the CDC guidelines for the use of a new regimen for the treatment of persons with latent tuberculosis infection. This is based on the 12-dose regimen for the treatment of latent TB infection (LTBI) - rifapentine and isoniazid once a week, for 12 weeks. Normal Side Effects include the fact that rifapentine may cause urine, saliva, tears, or sweat to appear an orange-red color. This is normal. If saliva and tears turn an orange-red color, contact lenses or dentures worn during treatment may become permanently stained.References:CDC | TB | Treatment for Latent TB Infection (LTBI) http://buff.ly/1nXrm5A Posted at Clinical Cases and Images. Stay updated and subscribe, follow us on Twitter and connect on Facebook.
Source: Clinical Cases and Images - Category: Journals (General) Tags: CDC Infectious Diseases Source Type: news